Specifications | Ultrafine aerosols and nanoparticles at the workplace \Focus on IFA s work, No. 0302\ IFA |
Business section |

Specifications | Ultrafine aerosols and nanoparticles at the workplace \Focus on IFA s work, No. 0302\ IFA |
Business section |
Specifications | Ultrafine aerosols and nanoparticles at the workplace \Focus on IFA s work, No. 0302\ IFA |
Suggested Link Details/Purchase | |
Content | 0302 Edition 10/2011 617.0-IFA:638.3 Ultrafine aerosols and nanoparticles at the workplace – www.dguv.de/ifa/nano Problem Nanotechnology is regarded as a technology of the future. Nanoparticles are already being used in many products, such as sunscreen and composite materials for sports equipment. The worldwide value of products containing nanoparticles is expected to rise to US$1 trillion by 2015. The areas of application range from medicine, through surface finishing, to materials science and the chemical industry. Nanoparticles is the colloquial term for objects with two or three dimensions of between 1 and 100 nanometres (nm) and manufactured specifi- cally for their particular properties. In the OSH sector, nanoparticles are distinguished from ultrafine particles (UFPs), which have similar dimensions but are produced incidentally, for example during combustion processes. The atmospheric limit value for the respirable dust fraction explicitly excludes UFPs; a workplace limit value does not therefore exist, either for UFPs or for nanoparticles. In addition, the transport and mode of action of the particles within the human body remain inadequately researched. This is a serious obstacle to assessment of workplace exposure. Particular attention is currently being paid to fibrous nanoparticles such as carbon nanotubes (CNTs). Some of these CNTs may satisfy the defi- nition for WHO fibres (length > 5 µm, diameter < 3 µm, length to diameter ratio > 3:1). Left: single-walled carbon nanotube; right: titanium dioxide (scanning electron microscopic image of nanostructured material); image: Finnish Institute of Occupational Health (FIOH) Whether the health hazard presented by these CNTs is comparable to that of other WHO fibres is the subject of current research. Activities The IFA is a partner in a number of projects and measurement programmes. The completed EU Nanosafe2 and NANOSH projects for example specifically studied exposure to nanoparticles, whereas the current EU NanoDevice project is focused upon the further development of suitable measurement techniques. A measurement pro- gramme conducted by the German accident insur- ance institutions is concerned with exposure to ultrafine dusts. The knowledge and experience gained will be contributed to German and interna- tional working groups and standards committees, in order for a co-ordinated procedure to be imple- mented for the measurement and assessment of exposure to nanoparticles. |
Navigation | Previous Page / Next Page |
Following Datasheets | aifa0304e_2 (2 pages) aifa0308e_2 (2 pages) aifa0310e_2 (2 pages) aifa0311e_2 (2 pages) aifa0312e_2 (2 pages) aifa0321e_1 (2 pages) aifa0322e_1 (2 pages) aifa0335e (2 pages) aifa0336e (2 pages) aifa0337e (2 pages) |
Check in e-portals![]() |
World-H-News Products Extensions Partners Automation Jet Parts |
Sitemap Folder | group1 group2 group3 group4 group5 group6 group7 group8 group9 group10 group11 group12 group13 group14 group15 group16 group17 group18 group19 group20 group21 group22 group23 group24 group25 group26 group27 group28 group29 group30 group31 group32 group33 group34 group35 group36 group37 group38 group39 group40 group41 group42 group43 group44 group45 group46 group47 group48 group49 group50 group51 group52 group53 group54 group55 group56 group57 group58 group59 group60 group61 group62 group63 group64 group65 group66 group67 group68 group69 group70 group71 group72 group73 group74 group75 group76 group77 group78 group79 group80 group81 group82 group83 group84 group85 group86 group87 group88 group89 group90 group91 group92 group93 group94 group95 group96 group97 group98 group99 group100 Prewious Folder Next Folder |